Fellowship · New York, NY
Sponsored by New York Presbyterian Hospital
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
The New England journal of medicine · 2022 · 158 citations · Abha Choudhary
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.
Obesity pillars · 2025 · 37 citations · Marisa Censani
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
European journal of endocrinology · 2022 · 101 citations · Zoltan Antal
Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023.
Obesity pillars · 2023 · 60 citations · Marisa Censani
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.
Journal of clinical lipidology · 2025 · 27 citations · Brenda Kohn
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3.
The Journal of clinical endocrinology and metabolism · 2023 · 37 citations · Paul Saenger
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
The Journal of clinical endocrinology and metabolism · 2022 · 51 citations · Paul Saenger
Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review.
Journal for immunotherapy of cancer · 2023 · 66 citations · Carly Barron